Revance Therapeutics Competitors and Similar CompaniesClear all

Revance Therapeutics's competitors and similar companies include Evofem Biosciences.
Revance Therapeutics
Revance Therapeutics
Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings.
Evofem Biosciences
Evofem Biosciences
Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.
Founding Date
Founding Date
2002
Founding Date
2007
Type
Type
Public
Type
Public
Tags
Locations
Locations
Nashville, US HQ
Irvine, US
Newark, US
Pleasanton, US
Locations
San Diego, US HQ
Employees
Employees
59712% increase
Employees
3030% increase
Valuation ($)
Valuation ($)
615.7 m
Valuation ($)
1.2 m

Financial

Revenue (est.)
Revenue (est.)
$234m (FY, 2023)
Revenue (est.)
$20.2m (FY, 2025)
Cost of goods
Cost of goods
$74.4m (FY, 2023)
Cost of goods
$4.6m (FY, 2025)
Gross profit
Gross profit
$159.7m (FY, 2023)
Gross profit
$15.6m (FY, 2025)
Net income
Net income
($324m) (FY, 2023)
Net income
$391k (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Evofem Biosciences
HQ
San Diego, US
Employees
30↑ 30% increase

Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.

View company